Diagonal Bio Feed

	Est. tid*
2025-10-31	08:00	Kvartalsrapport 2025-Q3
2025-08-22	-	Kvartalsrapport 2025-Q2
2025-05-21	-	X-dag ordinarie utdelning DIABIO 0.00 SEK
2025-05-20	-	Årsstämma
2025-05-14	-	Kvartalsrapport 2025-Q1
2025-03-28	-	Bokslutskommuniké 2024
2025-01-17	-	Extra Bolagsstämma 2024
2024-10-31	-	Kvartalsrapport 2024-Q3
2024-08-22	-	Kvartalsrapport 2024-Q2
2024-06-12	-	X-dag ordinarie utdelning DIABIO 0.00 SEK
2024-06-11	-	Årsstämma
2024-05-31	-	Kvartalsrapport 2024-Q1
2024-02-28	-	Bokslutskommuniké 2023
2023-10-31	-	Kvartalsrapport 2023-Q3
2023-09-22	-	Extra Bolagsstämma 2023
2023-08-22	-	Kvartalsrapport 2023-Q2
2023-05-12	-	X-dag ordinarie utdelning DIABIO 0.00 SEK
2023-05-11	-	Årsstämma
2023-05-11	-	Kvartalsrapport 2023-Q1
2023-02-23	-	Bokslutskommuniké 2022
2022-11-23	-	Extra Bolagsstämma 2022
2022-11-16	-	Kvartalsrapport 2022-Q3
2022-08-23	-	Kvartalsrapport 2022-Q2
2022-05-12	-	X-dag ordinarie utdelning DIABIO 0.00 SEK
2022-05-11	-	Årsstämma
2022-05-11	-	Kvartalsrapport 2022-Q1
2022-02-23	-	Bokslutskommuniké 2021
2021-10-29	-	Kvartalsrapport 2021-Q3
2021-08-27	-	Kvartalsrapport 2021-Q2

Land	Sverige
Lista	Nordic SME Sweden
Sektor	Hälsovård
Industri	Medicinteknik

2025-08-22 08:00:00 Diagonal Bio publishes interim report for the second quarter of 2025

2025-08-20 08:00:00 Diagonal Bio AB receives patent approval in Japan 0,01 SEK | 0,00% | 0,11 MSEK

2025-07-07 13:00:00 Diagonal Bio AB files patent application for Novel Computational Method that significantly improves LAMP primer design 0,01 SEK | +11,11% | 0,34 MSEK

2025-06-25 13:00:00 The Board of Directors of Diagonal Bio carries out a directed issue to underwriters in connection with exercise of warrants of series TO 2 0,01 SEK | -20,00% | 0,18 MSEK

2025-06-19 13:40:00 Diagonal Bio receives SEK 3.6 million through exercise of warrants of series TO 2 0,01 SEK | 0,00% | 0,04 MSEK

2025-06-17 18:47:00 Update regarding large shareholder’s exercise of warrants of series TO 2 0,01 SEK | 0,00% | 0,07 MSEK

2025-06-17 08:30:00 Diagonal Bio expands equine panel with addition of strangles 0,01 SEK | 0,00% | 0,18 MSEK

2025-06-16 08:30:00 Large shareholder exercises warrants of series TO 2 0,01 SEK | -9,09% | 0,08 MSEK

2025-06-13 08:00:00 Last day of trading in Diagonal Bio’s warrants of series TO 2 is 16 June 2025 0,01 SEK | +10,00% | 0,08 MSEK

2025-06-11 11:30:00 Diagonal Bio shares progress update on LAMPlify® commercial pilots 0,01 SEK | 0,00% | 0,28 MSEK

2025-06-09 14:00:00 Svea Bank AB invests SEK 0.5 million in Diagonal Bio AB through the exercise of warrants of series TO 2 0,01 SEK | 0,00% | 0,22 MSEK

2025-06-04 08:30:00 The exercise period for Diagonal Bio’s warrants of series TO 2 starts today 0,01 SEK | 0,00% | 0,11 MSEK

2025-05-20 14:00:00 Kommuniké från årsstämma den 20 maj 2025 i Diagonal Bio AB 0,01 SEK | +8,33% | 0,01 MSEK

2025-05-20 14:00:00 Bulletin from the Annual General Meeting on 20 May 2025 in Diagonal Bio AB 0,01 SEK | +8,33% | 0,01 MSEK

2025-05-16 12:45:00 Diagonal Bio secures 100 percent of forthcoming warrant exercise through pre-subscription and underwriting commitments 0,01 SEK | 0,00% | 0,11 MSEK

2025-05-14 08:00:00 Diagonal Bio publishes interim report for the first quarter of 2025 0,01 SEK | 0,00% | 0,07 MSEK

2025-05-05 14:50:00 Diagonal Bio accelerates its commercialisation efforts with the appointment of Anders Wallseth as Senior Commercial Advisor 0,01 SEK | -7,14% | 0,07 MSEK

2025-04-29 08:00:00 Diagonal Bio publishes the Annual Report for 2024 0,01 SEK | 0,00% | 0,03 MSEK

2025-04-25 08:00:00 Diagonal Bio announces change of news plattform 0,01 SEK | 0,00% | 0,07 MSEK

2025-04-14 11:05:15 Kallelse till årsstämma i Diagonal Bio AB 0,01 SEK | 0,00% | 0,17 MSEK

2025-03-28 08:45:00 Diagonal Bio announces additional pilot tests of LAMPlify® 0,01 SEK | +7,14% | 0,08 MSEK

2025-03-28 08:00:00 Diagonal Bio publishes Year-End Report for 2024 0,01 SEK | +7,14% | 0,08 MSEK

2025-03-21 14:00:00 Diagonal Bio granted patent in Japan 0,01 SEK | -6,25% | 0,24 MSEK

2025-03-19 14:00:00 Nomination Committee change in Diagonal Bio AB (publ.) 0,01 SEK | +3,45% | 0,08 MSEK

2025-03-19 08:30:00 Trading in Diagonal Bio’s shares and warrants of series TO 2 on NGM Nordic SME begins today 0,01 SEK | +3,45% | 0,08 MSEK

2025-03-13 09:45:00 Stall Courant and Diagonal Bio agree to a pilot test of LAMPlify® 0,01 SEK | +5,88% | 0,25 MSEK

2025-03-04 16:44:41 Diagonal Bio has been approved for delisting from Nasdaq First North Growth Market 0,01 SEK | -3,47% | 0,10 MSEK

2025-03-04 15:42:40 Diagonal Bio has received conditional approval for listing on NGM Nordic SME 0,01 SEK | -3,47% | 0,10 MSEK

2025-03-03 09:54:46 Diagonal Bio applies for change of marketplace to NGM Nordic SME 0,01 SEK | -3,36% | 0,17 MSEK

2025-02-19 14:45:00 Diagonal Bio AB’s announces last day of trading in BTU and first day of trading in warrants of series TO 2 0,02 SEK | -4,76% | 0,11 MSEK

2025-02-18 14:30:00 Diagonal Bio AB resolves on a directed issue of units to all external underwriters 0,02 SEK | +8,00% | 0,08 MSEK

2025-02-12 15:45:00 Diagonal Bio’s CEO Karin Wehlin increases ownership 0,03 SEK | +35,87% | 1,20 MSEK

2025-02-07 16:15:00 Diagonal Bio AB’s rights issue of units oversubscribed 0,02 SEK | -5,39% | 0,08 MSEK

2025-02-05 19:45:00 Stall Goop conducts pilot test of LAMPlify® 0,02 SEK | +5,03% | 0,05 MSEK

2025-01-29 09:40:00 Diagonal Bio announces positive pilot test results and secures order from StallZet 0,02 SEK | +2,92% | 0,40 MSEK

2025-01-23 08:30:00 The subscription period of Diagonal Bio AB’s rights issue of units commences today 0,02 SEK | -10,82% | 0,14 MSEK

2025-01-22 08:30:00 Diagonal Bio AB publishes investment memorandum prior to upcoming rights issue of units 0,02 SEK | -15,65% | 0,22 MSEK

2025-01-17 15:30:00 Nomination Committee change in Diagonal Bio (publ.) 0,02 SEK | -2,44% | 0,08 MSEK

2025-01-17 13:45:00 Bulletin from the Extraordinary General Meeting of Diagonal Bio AB on 17 January 2025 0,02 SEK | -2,44% | 0,08 MSEK

2025-01-14 22:00:00 Diagonal Bio expands its testing panel for horses with EHV-5 detection 0,01 SEK | +4,07% | 0,04 MSEK

2024-12-23 23:02:13 Kallelse till extra bolagsstämma i Diagonal Bio AB 0,02 SEK | -6,98%

2024-12-23 22:54:25 The Board of Directors of Diagonal Bio AB resolves on a directed issue of units and a rights issue of units to focus on validation of LAMPlify®’s commercial interest 0,02 SEK | -6,98%

2024-12-23 21:46:53 Diagonal Bio enters into a strategic partnership with Daniel Redén at StallZet to enhance commercialisation plans 0,02 SEK | -6,98%

2024-11-22 12:30:00 Renowned horse race jockey and trainer conducts pilot test of LAMPlify® 0,02 SEK | +3,05% | 0,50 MSEK

2024-11-18 16:00:00 Valberedning utsedd i Diagonal Bio AB (publ) inför årsstämman 2025 0,02 SEK | +9,09% | 0,13 MSEK

2024-11-18 16:00:00 Nomination Committee appointed for Diagonal Bio 0,02 SEK | +9,09% | 0,13 MSEK

2024-11-13 15:00:00 Diagonal Bio announces pilot test with LAMPlify® at Kolgjini Stables 0,02 SEK | +8,57% | 0,47 MSEK

2024-11-11 08:00:00 Diagonal Bio announces that it is exploring financing options 0,02 SEK | -4,18% | 0,47 MSEK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Diagonal Bio

Prenumeration

Kalender

Beskrivning

Diagonal Bio

Prenumeration

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden